Page 9 - Toddler Development News Today

Long-term efficacy data from the pivotal SUNFISH study confirm increases in motor function are sustained at three years while adverse events decreased over the same periodPart 2 of SUNFISH... | March 16, 2022

Investegate announcements from F. Hoffmann-La Roche Ltd, New data for Roche’s Evrysdi (risdiplam) demonstrate long-term efficacy and safety in a broad population of people with spinal muscular atrophy (SMA)

Long-term efficacy data from the pivotal SUNFISH study confirm increases in motor function are sustained at three years while adverse events decreased over the same periodPart 2 of SUNFISH showed Evrysdi

Apple TV+ has unveiled a kids’ changemakers initiative designed to bring “world renowned education leaders together with the world’s most creative storytellers to create inspiring and enriching original series for kids.” Tara Sorensen, Apple’s head of kids programming, says the initiative encourages

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review of a...

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review of a...

FDA Grants Evrysdi® Priority Review Based on Results From Treating Pre-Symptomatic Infants with Spinal Muscular Atrophy– RAINBOWFISH study interim results showed that after treatment with Evrysdi pre-symptomatic infants with spinal muscular atrophy achieved same motor milestones as healthy infants –S...

Why do kids regress, and what should parents do about it?

Trial shows inconclusive results -- and an unexpected cognitive finding

By Samantha Murphy Kelly, CNN Business Meditation toys to help kids manage their feelings. A Lego kit for coding, with a focus on problem-solving skills. And an